208TiP SOLTI-1303 PATRICIA: Cohort C. Combination of palbociclib with trastuzumab and endocrine therapy (ET) versus treatment of physician’s choice (TPC) in pretreated HER2-positive and hormone receptor-positive (HER2+/HR+) / PAM50 luminal metastatic breast cancer (BC): A randomized phase II trial

Saved in:
Bibliographic Details
Published inAnnals of oncology Vol. 33; pp. S222 - S223
Main Authors Ciruelos, E.M., Ponce, J., Pernas Simon, S., Cortés, J., Cantos, B., Garate, E., Vega Alonso, E., Mele Olive, M., Martinez De Dueñas, E., Montaño Perianez, A., Martinez, N., Perello Martorell, A., Bermejo De Las Heras, B., Arqueros Nunez, C., Fernández, I., De la Haba Rodriguez, J., Oliveira, M., González, X., Villagrasa Gonzalez, P., Prat, A.
Format Journal Article
LanguageEnglish
Published Elsevier Ltd 01.05.2022
Online AccessGet full text

Cover

More Information
ISSN:0923-7534
1569-8041
DOI:10.1016/j.annonc.2022.03.227